Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022

Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022

We studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021–February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5′ end of the spike gene in 2 epidemiologically linked case-patients. Continued surveillan...

Full description

Bibliographic Details
Main Authors: Haogao Gu, Daisy Y.M. Ng, Gigi Y.Z. Liu, Samuel S.M. Cheng, Pavithra Krishnan, Lydia D.J. Chang, Sammi S.Y. Cheuk, Mani M.Y. Hui, Tommy T.Y. Lam, Malik Peiris, Leo L.M. Poon
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-06-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
respiratory infections
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
SARS
coronavirus disease
Online Access:https://wwwnc.cdc.gov/eid/article/28/6/22-0523_article
Description
Summary:We studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021–February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5′ end of the spike gene in 2 epidemiologically linked case-patients. Continued surveillance for SARS-CoV-2 recombinants is needed.
ISSN:1080-6040
1080-6059

Similar Items